352 results on '"Pfisterer, Matthias"'
Search Results
2. Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?
3. Prasugrel vs. clopidogrel in contemporary Western European patients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohorts
4. Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus
5. Prognostic Usefulness of Cardiac Stress Test Modalities in Patients With Type 2 Diabetes Mellitus Who Underwent Myocardial Perfusion Scintigraphy (from the Basel Asymptomatic High-Risk Diabetics' Outcome Trial)
6. Quality of life as predictor for the development of cardiac ischemia in high-risk asymptomatic diabetic patients
7. Predicting hospitalization and mortality in patients with heart failure: The BARDICHE-index
8. Frequency of Cardiac Death and Stent Thrombosis in Patients With Chronic Obstructive Pulmonary Disease Undergoing Percutaneous Coronary Intervention (from the BASKET-PROVE I and II Trials)
9. Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials
10. Novel concept to guide systolic heart failure medication by repeated biomarker testing—results from TIME-CHF in context of predictive, preventive, and personalized medicine
11. Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study
12. Initial systolic blood pressure associates with systemic inflammation, myocardial injury, and outcomes in patients with acute coronary syndromes.
13. Improvement in left ventricular ejection fraction and reverse remodeling in elderly heart failure patients on intense NT-proBNP-guided therapy
14. Differential Prognostic Impact of Resting Heart Rate in Older Compared With Younger Patients With Chronic Heart Failure—Insights From TIME-CHF
15. Prognostic Value of “Routine” Cardiac Stress Imaging 5 Years After Percutaneous Coronary Intervention: The Prospective Long-Term Observational BASKET (Basel Stent Kosteneffektivitäts Trial) LATE IMAGING Study
16. Interaction Between Pulmonary Hypertension and Diastolic Dysfunction in an Elderly Heart Failure Population
17. Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes — results from the BASKET PROVE trial
18. Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease
19. Impact of stent diameter and length on in‐stent restenosis after DES vs BMS implantation in patients needing large coronary stents—A clinical and health‐economic evaluation
20. Frequency and Predictors of Hyperkalemia in Patients ≥60 Years of Age With Heart Failure Undergoing Intense Medical Therapy
21. Drug Eluting and Bare Metal Stents in People with and without Diabetes: Collaborative Network Meta-Analysis
22. Raised cardiac troponins: Causes extend beyond acute coronary syndromes
23. Management of stable coronary artery disease
24. Predictors of early readmission or death in elderly patients with heart failure
25. Impact of worsening renal function related to medication in heart failure
26. Comparison of Six-Month Outcomes for Primary Percutaneous Revascularization for Acute Myocardial Infarction With Drug-Eluting Versus Bare Metal Stents (from the APEX-AMI Study)
27. Percutaneous coronary intervention in the Occluded Artery Trial: Procedural success, hazard, and outcomes over 5 years
28. Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina—Comparison of the effects of drug-eluting versus bare-metal stents
29. Sudden Cardiac Death in Patients With Silent Myocardial Ischemia After Myocardial Infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II])
30. How reliable are left ventricular ejection fraction cut offs assessed by echocardiography for clinical decision making in patients with heart failure?
31. Supplement to: Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
32. Use of B-type natriuretic peptide outside of the emergency department
33. Outpatient Rehabilitation in Patients With Coronary Artery and Peripheral Arterial Occlusive Disease
34. Gate-keeper to coronary angiography: comparison of exercise testing, myocardial perfusion SPECT and individually tailored approach for risk stratification
35. Drug-eluting versus bare-metal stents in large coronary arteries
36. Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis
37. Interrelation of ST-segment depression during bicycle ergometry and extent of myocardial ischaemia by myocardial perfusion SPECT
38. Drug-eluting stents with biodegradable polymers: are enough data in for a final assessment?
39. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial
40. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology
41. Long-term safety of drug-eluting stents
42. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)
43. Drug Treatment of Chronic Heart Failure in the Elderly
44. Erhöhtes Risiko für Stentthrombosen bei DES?
45. Hemodynamic Parameters Are Prognostically Important in Cardiogenic Shock But Similar Following Early Revascularization or Initial Medical Stabilization: A Report From the SHOCK Trial
46. A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
47. Effects of percutaneous coronary interventions in silent ischemia after myocardial infraction
48. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents
49. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
50. Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.